Literature DB >> 7954344

Pathology and clinical evolution of ductal carcinoma in situ (DCIS) of the breast.

D L Page1, M D Lagios.   

Abstract

The therapy of ductal carcinoma in situ is controversial, but is being more and more decided by the pathologic evidence. What we know of the natural history of ductal carcinoma in situ is that the comedo and non-comedo examples seem quite different. As detailed in several reviews, the information from studies following patients after biopsy alone indicate a great difference between the small non-comedo examples of ductal carcinoma in situ and the larger comedo DCIS. The currently available evidence from cases which have been treated by planned surgical excision without radiation therapy would indicate that the non-comedo examples of DCIS may be adequately treated by this modality as indicated in several recent studies.

Entities:  

Mesh:

Year:  1994        PMID: 7954344     DOI: 10.1016/0304-3835(94)90173-2

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  2 in total

1.  Physical confinement induces malignant transformation in mammary epithelial cells.

Authors:  Yen-Chun Lu; Tinyi Chu; Matthew S Hall; Dah-Jiun Fu; Quanming Shi; Alan Chiu; Duo An; Long-Hai Wang; Yehudah Pardo; Teresa Southard; Charles G Danko; Jan Liphardt; Alexander Yu Nikitin; Mingming Wu; Claudia Fischbach; Scott Coonrod; Minglin Ma
Journal:  Biomaterials       Date:  2019-06-26       Impact factor: 12.479

2.  COX-2 and PPARgamma expression are potential markers of recurrence risk in mammary duct carcinoma in-situ.

Authors:  Swati Kulkarni; Deepa B Patil; Leslie K Diaz; Elizabeth L Wiley; Monica Morrow; Seema A Khan
Journal:  BMC Cancer       Date:  2008-01-31       Impact factor: 4.430

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.